David Maddison Clinical Sciences Building / Westmead Hospital / Westmead Millennium Institute / Calvary Mater Newcastle Hospital / University of Sydney / 2Westmead Institute / /
IndustryTerm
treatment of melanoma / protein product / in vitro systems / treatment of B-RAFV600E melanoma / also been shown in varying in vitro systems / /
MedicalCondition
Cancer / another three B-RAF-mutant melanoma / Disease / wild-type B-RAF melanoma / mutant B-RAF melanoma / another two B-RAFV600E melanoma / additional three B-RAFmutant melanoma / mutant and wild-type B-RAF melanoma / B-RAF-mutant melanoma / metastatic mutant B-RAF melanomas / melanomas / human melanoma / melanoma / B-RAFV600E melanoma / fresh melanoma / /
Organization
Immunology and Oncology Unit / Calvary Mater Newcastle Hospital / Westmead Millennium Institute / University of Sydney / Westmead Hospital / 2Westmead Institute for Cancer / /
Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS